Beyond Air, Inc.

Beyond Air, Inc. reported a 107% increase in fiscal year 2026 revenue to $7.7 million, alongside a net loss of $33.2 million. The company announced a change in its fiscal year-end from March 31 to December 31, effective December 31, 2026. Beyond Air also provided revenue guidance of $8 million for calendar year 2026 and $16-$18 million for calendar year 2027, anticipating significant growth driven by its second-generation LungFit PH system, which is currently under FDA review.

Beyond Air, Inc. provided a comprehensive business update in its 10-K filing, highlighting significant progress across its nitric oxide (NO) platform. The company received European CE mark approval for its LungFit PH system in November 2024, leading to regulatory approvals in over 27 countries and distribution agreements in over 40 countries outside the U.S. Additionally, Beyond Air submitted a PMA supplement for its next-generation LungFit PH II to the FDA in June 2025, aiming to expand its addressable market. The filing also detailed positive clinical trial results for LungFit PRO in viral lung infections and bronchiolitis, and for LungFit GO in NTM lung disease, alongside progress in oncology and neurology programs through its subsidiaries. However, the auditor's report expressed substantial doubt about the company's ability to continue as a 'going concern'.

Beyond Air, Inc. announced strong financial results for fiscal year 2026, with revenue increasing 107% to $7.7 million, driven by demand for LungFit PH. The company provided optimistic revenue guidance of $16-$18 million for calendar year 2027, anticipating significant growth from the potential FDA approval of its second-generation LungFit PH system. However, the company reported a net loss of $33.2 million for FY2026 and implemented a 1-for-20 reverse stock split to maintain Nasdaq listing compliance.

Beyond Air, Inc. announced that its stockholders approved a reverse stock split proposal at a special meeting held on June 18, 2026. Immediately following the approval, the Board of Directors authorized a 1-for-20 reverse stock split. The company intends to implement this action to increase its per share bid price above $1.00 and regain compliance with Nasdaq listing rules by the July 31, 2026 deadline, though it cannot assure the split will be implemented or achieve the desired effects.

Beyond Air, Inc. announced that the Nasdaq Hearings Panel granted its request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The company must regain compliance with the Nasdaq Bid Price Rule by July 31, 2026. Additionally, Beyond Air will be under a one-year Discretionary Panel Monitor, where any further non-compliance could lead to immediate delisting without a new compliance plan. Shareholders are scheduled to vote on a reverse stock split on June 18, 2026, as a measure to meet the bid price requirement.

Beyond Air, Inc. announced a Special Meeting of Stockholders on June 18, 2026, to vote on a proposed reverse stock split. The company seeks approval for a reverse split at a ratio between 1-for-2 and 1-for-20, with the exact ratio to be determined by the Board. This action is primarily aimed at increasing the per share market price of its common stock to regain compliance with Nasdaq's minimum $1.00 bid price requirement. The company received a delisting notice from Nasdaq on April 7, 2026, and is not eligible for a compliance period due to a previous 1-for-20 reverse stock split in July 2025. A hearing with the Nasdaq Hearings Panel is scheduled for May 14, 2026.

Beyond Air, Inc. received a notice from Nasdaq's Listing Qualifications Department stating non-compliance with the $1.00 bid price requirement. The company has timely requested a hearing before the Nasdaq Hearings Panel to appeal this determination. As a result, the delisting action is stayed, and the company's common stock is expected to continue trading on Nasdaq pending the outcome of the hearing, which is scheduled for May 14, 2026.

Beyond Air, Inc. announced that CEO Robert Goodman and CFO Dan Moorhead will participate in the D. Boral Capital Global Conference 2026. The conference will be held on Thursday, May 7th, at The Plaza Hotel in New York, featuring one-on-one meetings. This participation offers an opportunity for investor engagement.

Beyond Air, Inc. received a delisting notification from Nasdaq on April 7, 2026, for failing to maintain the minimum $1.00 bid price requirement. The company's common stock traded below $1.00 for 30 consecutive business days from February 23, 2026, to April 6, 2026. Due to a reverse stock split effected within the prior year, Beyond Air is not eligible for the standard 180-calendar day compliance period. The company plans to timely request a hearing before the Nasdaq Hearings Panel by April 14, 2026, which will stay any further delisting action.